ENBIO Statistics

Total Valuation

ENBIO has a market cap or net worth of KRW 29.13 billion. The enterprise value is 45.88 billion.

Market Cap	29.13B
Enterprise Value	45.88B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ENBIO has 10.87 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	10.87M
Shares Outstanding	10.87M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.16%
Owned by Institutions (%)	n/a
Float	6.94M

Valuation Ratios

The trailing PE ratio is 87.75.

PE Ratio	87.75
Forward PE	n/a
PS Ratio	0.86
PB Ratio	0.67
P/TBV Ratio	0.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.63, with an EV/FCF ratio of -9.66.

EV / Earnings	138.24
EV / Sales	1.35
EV / EBITDA	16.63
EV / EBIT	38.66
EV / FCF	-9.66

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.44.

Current Ratio	1.80
Quick Ratio	0.10
Debt / Equity	0.44
Debt / EBITDA	7.04
Debt / FCF	-4.09
Interest Coverage	1.82

Financial Efficiency

Return on equity (ROE) is 0.76% and return on invested capital (ROIC) is 1.20%.

Return on Equity (ROE)	0.76%
Return on Assets (ROA)	1.00%
Return on Invested Capital (ROIC)	1.20%
Return on Capital Employed (ROCE)	2.46%
Revenue Per Employee	423.42M
Profits Per Employee	4.15M
Employee Count	80
Asset Turnover	0.46
Inventory Turnover	1.18

Taxes

In the past 12 months, ENBIO has paid 201.41 million in taxes.

Income Tax	201.41M
Effective Tax Rate	37.77%

Stock Price Statistics

The stock price has decreased by -4.64% in the last 52 weeks. The beta is 0.96, so ENBIO's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-4.64%
50-Day Moving Average	2,572.90
200-Day Moving Average	2,302.35
Relative Strength Index (RSI)	53.44
Average Volume (20 Days)	14,909

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ENBIO had revenue of KRW 33.87 billion and earned 331.85 million in profits. Earnings per share was 30.54.

Revenue	33.87B
Gross Profit	11.01B
Operating Income	1.19B
Pretax Income	533.26M
Net Income	331.85M
EBITDA	2.76B
EBIT	1.19B
Earnings Per Share (EPS)	30.54

Full Income Statement

Balance Sheet

The company has 2.68 billion in cash and 19.43 billion in debt, giving a net cash position of -16.75 billion or -1,541.26 per share.

Cash & Cash Equivalents	2.68B
Total Debt	19.43B
Net Cash	-16.75B
Net Cash Per Share	-1,541.26
Equity (Book Value)	43.79B
Book Value Per Share	4,029.12
Working Capital	21.14B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.19 billion and capital expenditures -562.88 million, giving a free cash flow of -4.75 billion.

Operating Cash Flow	-4.19B
Capital Expenditures	-562.88M
Free Cash Flow	-4.75B
FCF Per Share	-436.92

Full Cash Flow Statement

Margins

Gross margin is 32.51%, with operating and profit margins of 3.50% and 0.98%.

Gross Margin	32.51%
Operating Margin	3.50%
Pretax Margin	1.57%
Profit Margin	0.98%
EBITDA Margin	8.14%
EBIT Margin	3.50%
FCF Margin	n/a

Dividends & Yields

ENBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	n/a
Earnings Yield	1.14%
FCF Yield	-16.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ENBIO has an Altman Z-Score of 1.19 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.19
Piotroski F-Score	4